Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 May 5;47(1):65-9.
doi: 10.1007/BF00428703.

Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics

Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics

I D Hirschhorn et al. Psychopharmacology (Berl). .

Abstract

The present investigation sought to determine whether the stimulus properties of morphine and lysergic acid diethylamide (LSD) would generalize to several narcotic analgesics which vary in their subjective effects. Morphine and saline served as discriminative stimuli for one group of rats in a 2-lever discrimination task. LSD and saline were discriminative stimuli for a second group. Depression of one lever in an operant chamber resulted in reinforcement following the administration of morphine or LSD and the opposite lever was reinforced after saline. After discriminated responding was stable, stimulus generalization tests with narcotic analgesics and antagonists showed that the stimulus properties of morphine generalized to methadone and meperidine, and partially to pentazocine, all of which produce morphine-like subjective effects in humans. Morphine stimulus properties did not generalize to nalorphine or cyclazocine, which produce dissimilar subjective effects. The stimulus properties of LSD generalized partially to cyclazocine, but not to nalorphine. In humans cyclazocine and nalorphine produce a high incidence of psychotomimetic effects, but the subjective effects of cyclazocine are differentiable from those of LSD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1970 May-Jun;11(3):385-403 - PubMed
    1. Clin Pharmacol Ther. 1966 Nov-Dec;7(6):740-51 - PubMed
    1. J Pharmacol Exp Ther. 1965 Dec;150(3):437-42 - PubMed
    1. J Pharmacol Exp Ther. 1964 Feb;143:157-64 - PubMed
    1. J Pharmacol Exp Ther. 1969 May;167(1):1-8 - PubMed

Publication types

LinkOut - more resources